- Home
- MERC vs TERN Comparison
MERC vs TERN Comparison
Compare MERC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MERC
- TERN
- Stock Information
- Founded
- MERC 1968
- TERN 2017
- Country
- MERC Canada
- TERN United States
- Employees
- MERC N/A
- TERN N/A
- Industry
- MERC Paper
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- MERC Basic Materials
- TERN Health Care
- Exchange
- MERC Nasdaq
- TERN Nasdaq
- Market Cap
- MERC 422.6M
- TERN 382.2M
- IPO Year
- MERC 1987
- TERN 2021
- Fundamental
- Price
- MERC $6.51
- TERN $4.45
- Analyst Decision
- MERC Hold
- TERN Buy
- Analyst Count
- MERC 2
- TERN 5
- Target Price
- MERC $7.75
- TERN $18.30
- AVG Volume (30 Days)
- MERC 332.3K
- TERN 1.8M
- Earning Date
- MERC 02-20-2025
- TERN 03-13-2025
- Dividend Yield
- MERC 4.66%
- TERN N/A
- EPS Growth
- MERC N/A
- TERN N/A
- EPS
- MERC N/A
- TERN N/A
- Revenue
- MERC $2,025,449,000.00
- TERN N/A
- Revenue This Year
- MERC $5.02
- TERN N/A
- Revenue Next Year
- MERC $0.86
- TERN N/A
- P/E Ratio
- MERC N/A
- TERN N/A
- Revenue Growth
- MERC N/A
- TERN N/A
- 52 Week Low
- MERC $5.33
- TERN $4.32
- 52 Week High
- MERC $11.20
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- MERC 52.43
- TERN 27.09
- Support Level
- MERC $6.22
- TERN $4.38
- Resistance Level
- MERC $6.61
- TERN $5.95
- Average True Range (ATR)
- MERC 0.21
- TERN 0.29
- MACD
- MERC -0.00
- TERN -0.09
- Stochastic Oscillator
- MERC 58.00
- TERN 4.46
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The solid wood segment consists of the manufacture, sale, and distribution of lumber, manufactured products wood pallets, electricity, biofuels, and wood residuals from sawmills and other facilities located in Germany and the United States. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.